SCHEMBL5406765

SCHEMBL5406765

COC(=O)C=CC(Cc1ccccc1)NC(=O)OC(C)(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.53
ACE P12821 1/20 0.52
CTSS P25774 2/20 0.51
CTSL P07711 2/20 0.51
CTSB P07858 1/20 0.51
CTSK P43235 1/20 0.51
APP P05067 1/20 0.49
KLK5 Q9Y337 2/20 0.48
PPARA Q07869 2/20 0.47
PPARG P37231 1/20 0.47
KMT2A Q03164 2/20 0.47
ALDH1A1 P00352 3/20 0.47
LMNA P02545 2/20 0.46
PKM P14618 2/20 0.46
HPGD P15428 2/20 0.46
TSHR P16473 2/20 0.46
HTT P42858 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
HSD17B10 Q99714 2/20 0.46
TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5406769 1.00 ATM (0.53) ATMACECTSSCTSLCTSB
SCHEMBL5414251 1.00 ATM (0.53) ATMACECTSSCTSLCTSB
SCHEMBL5406758 1.00 ATM (0.53) ATMACECTSSCTSLCTSB
SCHEMBL5414264 1.00 ATM (0.53) ATMACECTSSCTSLCTSB
SCHEMBL5416888 1.00 ATM (0.53) ATMACECTSSCTSLCTSB
SCHEMBL2736190 0.91 ATM (0.61) ATMACECTSSCTSLCTSB
SCHEMBL12137049 0.91 ATM (0.61) ATMACECTSSCTSLCTSB
SCHEMBL5356751 0.90 PTPN1 (0.53) ATMCTSLPPARAPPARGRAB9A
SCHEMBL5356760 0.90 PTPN1 (0.53) ATMCTSLPPARAPPARGRAB9A
SCHEMBL5356756 0.90 PTPN1 (0.53) ATMCTSLPPARAPPARGRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111094238-B Carbamoyl phenylalaninol analogues and uses thereof 杰资制药爱尔兰有限公司 2023-06-09 CN disclosed
US-7202269-B2 GlyT2 modulators JANSSEN PHARMACEUTICA N.V. (BE) 2007-04-10 US disclosed
US-20050119245-A1 GlyT2 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2005-06-02 US disclosed
WO-2005044810-A1 GLYT2 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2005-05-19 WO disclosed
US-6127546-A Process for the preparation of oxazoline compound DONG KOOK PHARMACEUTICAL CO., LTD. (KR) 2000-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119245-A1 GlyT2 modulators GLRB, GLRA1, GLRA2 ATM 2145/4885ACE 2817/4885CTSS 3490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.